HCW Biologics Inc.
corporate_fare Company Profile
HCW Biologics Inc. (NASDAQ:HCWB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 65 items for HCWB at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- HCW Biologics Finalizes $1.5M Units Offering with Warrants to Address Going Concern
- HCW Biologics Amends Offering to Seek $5M via Units at Discount, Signaling Reduced Capital Raise
- HCW Biologics Secures $7M Licensing Deal, Forms JV for Key Asset Development
- HCW Biologics Files S-1 for $10M Offering to Address Going Concern and Nasdaq Compliance
- HCW Biologics Registers Resale of 3.4M Shares, Over 100% of Outstanding Equity, Amidst Going Concern Warning
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$54.23K
Net Income
-$7.96M
Diluted EPS
-$10.63
Op. Cash Flow
-$13.39M
Free Cash Flow
-$13.39M
Gross Profit
$10.85K
Operating Income
-$13.16M
Cash & Equivalents
$1.95M
Total Debt
$6.81M
Debt / Equity
2.46×
Net Margin
-146.77×
Shares Outstanding
2.1M sh
Source: 10-K · filed 2026-03-31 · accession 0001193125-26-134934
show_chartPrice Chart
Loading chart...
feed HCWB - Filings & News (Page 4)
HCWB
Feb 19, 2026, 3:46 PM EST
Price at Filing:
$0.5727
Real-time Price:
$0.7673
Change:
Reverse Stock Split
Market Cap:
$2.352M
HCWB
Feb 17, 2026, 9:09 AM EST
Price at Filing:
$0.711
Real-time Price:
$0.7673
Change:
Reverse Stock Split
Market Cap:
$2.352M
HCWB
Feb 13, 2026, 8:38 AM EST
Price at Filing:
$0.916393
Real-time Price:
$0.7673
Change:
Reverse Stock Split
Market Cap:
$2.352M
HCWB
Feb 11, 2026, 5:27 PM EST
Price at Filing:
$1.04
Real-time Price:
$0.7673
Change:
Reverse Stock Split
Market Cap:
$2.352M
HCWB
Jan 09, 2026, 4:49 PM EST
Price at Filing:
$1.22
Real-time Price:
$0.7673
Change:
Reverse Stock Split
Market Cap:
$2.352M